Vascular injury induces expression of periostin: A novel vascular extracellular matrix protein via the P13-kinase-MAP kinase pathway  by Li, Guohong et al.
34A ABSTRACTS - Angiography & Interventional Cardiology JACC March 19,2003 
model, highlighting this receptor’s potential role in the prevention of restenosis in the dia- 
betic patients.. 
Table. Morphometric Data 
Zucker fat rats Zucker lean rats 
Placebo Treatment Placebo Treatment 
(n=12) (n=6) (n=lO) (n=7) 
Luminal area (mm2) 0.15+0.05 0.22+0.06’ 0.21iO.04 0.23*0.04 
Neointimal Area (IA, mn+) 0.21+0.05 0.15iO.05’ 0.14-tO.06 0.12*0.03 
Medial Area (MA, mr$) 0.10*0.01 0.10*0.01 0.11*0.03 0.10+0.01 
External Elastic Lamina (mm?) 0.45kO.05 0.47*0.05 0.46+0.05 0.44+0.04 
IA/MA 2.10i0.47 1.43i0.47’ 1.21~0.41 1.21*0.30 
* P-z 0.05 when compared with placebo. 
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808-3 Vascular Injury Induces Expression of Periostin: A 
Novel Vascular Extracellular Matrix Protein via the Pl3- 
Kinase-MAP Kinase Pathway 
Guohono Li, David Wang, Yiu-Fai Chen, Suzanne Oparil, University of Alabama at 
Birmingham, Birmingham, AL 
Periostin (PN, also known as osteoblast-specific factor-2, OSF2), is a novel cell adhesion 
protein secreted by osteoblasts and osteoblast-like cell lines that has been described in 
the embryonic heart but not in adult cardiovascular tissues. Based on previous findings 
from our laboratory and others that extracellular matrix (ECM) proteins such as 
osteopontin (OPN) play an important role in vascular remodeling following endoluminal 
injury, we tested the hypotheses that PN is expressed in arteries in the setting of acute 
vascular injury and explored the signaling mechanisms involved using rat aortic smooth 
muscle cells (RASMCs) in vitro. Sprague Dawley rats (male, lo-wk old) were subjected 
to balloon injury of the right carotid artery and sacrificed at 3 days (n=7) and 7 days (n=6) 
post injury. Uninjured right carotid arteries from sham-operated rats were used as con- 
trols (n = 6). PN and OPN mRNA expression was analyzed by Northern blot. PN and 
OPN mRNA were undetectable in uninjured control vessels but increased post injury, 
with a peak at 3 days. PN mRNA expression in cultured RASMCs was robustly stimu- 
lated by growth factors (10 @ml of FGF-1, PDGF-66) and angiotensin II (100 nM), (2.5- 
, 2-, and 3.2- fold increases), respectively. This stimulatoiy effect was completely inhib- 
ited by pretreatment with either the PI3 kinase inhibitor (LY294002, 10 uM) or the MAP 
kinase inhibitor (U0126, 5 uM). In contrast, OPN mRNA expression was not affected by 
LY294002 and only partially (50%) inhibited by UO126 This study provides a first demon- 
stration that vascular injury induces PN expression, likely via the PIS-kinase- MAP kinase 
pathway, suggesting a contribution of this novel ECM protein to neointima formation fol- 
lowing vascular injury. 
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808-4 Systemic Markers of Inflammation Do Not Predict 
Coronary In-Stent Restenosis in Stable Angina Patients 
Treated With HMG CoA Reductase Inhibitors 
Abuzeid Gomma. Gideon Hirschfield June Gallimore, Gordon Lowe, Mark Pepys, Kim 
Fox, National Heart and Lung Institute and Royal Brompton Hospital. London, United 
Kingdom, Royal Free and University College Medical School, London, United Kingdom 
Introduction: C-reactive protein (CRP), serum amyloid A protein (SAA), and interleukin- 
6 (IL-6) can predict coronary r&stenosis following angioplasty and stent deployment. In 
view of the anti-inflammatory activity of HMG CoA reductase inhibitors (statins), we 
reviewed this association in statin treated stable angina patients, undergoing angioplasty 
and stenting. Methods: We investigated this association in 162 stable angina patients, in 
whom 152 underwent elective coronary artery stenting and a further 30, diagnostic 
angiography alone. of the patients as a whole, 60% were receiving HMG CoA reductase 
inhibitors, At 6 months 133 stented patients were restudied and the target lesions quanti- 
fied. Baseline and serial CRP, SAA and IL-6 values were measured by high sensitivity 
immunoassays; values are reported as medians. Results: The binary restenosis rate at 
follow-up was 33.6%. There were no significant differences in values of CAP, SAA or IL- 
6 between patients with or without in-stem restenosis. Patients with pre-procedural val- 
ues of CRP. SAA or IL-6 greater than the median, continued to have elevated values at 
follow up.Pre-procedural values of CRP and SAA did not differ between patients under- 
going angiography alone or angioplasty plus stenting (CRP: 3.7mg/l vs 3mg/l; SAA: 
4.lmgIt vs 3.5mgIl). despite a small difference in values of IL-6 (1.92pg/ml YS 2.76pg/ml, 
PzO.02). Pre-procedural values of CRP, but not SAA or IL-6, correlated positively with 
BMI (P=O.Ol). Higher values of CRP (5.95 mg/l vs 2,95mg/l. PzO.09) and SAA (4.9mg/l 
vs amgil, PzO.026) were seen in women. while smokers or ex-smokers had elevated val- 
ues of CRP (365mg/l vs 2.15mgA. P<O.OOi). Conclusion: Pm- or peri-procedural vai- 
ues of CRP, SAA or IL-6, are not associated with coronary in-stent restenosis in stable 
angina patients in contrast to previous report in patients predominantly with unstable 
angina. In addition to differences in pathobiology between stable and unstable coronary 
syndromes, the widespread use of statins with anti-inflammatory activity, reflected by 
suppression of CRP production, may mask the association. 
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808-5 Obligate Role of Macrophage Colony-Stimulating Factor 
for the Development of Neointimal Thickening 
Following Arterial Injury 
Trioathi B. Raiavashisth. Ming Liu, Hiroyuki Tanaka, Jagannath Tripathi, Pinky Tripathi, 
Arthur Loussararian, Peter Libby, Hiroyasu Uzui. Aatish Kumar, Terence M. Doherty, 
Bojan Cercek, Sanjay Kaul, Prediman K. Shah, Cedars-Sinai Medical Center, Los 
Angeles, CA, Brigham &Women’s Hospital and Harvard Medical School, Boston, MA 
Although evidence suggests that macrophage-colony stimulating factor (M-CSF) panici- 
pates critically in atherosclerosis, little is known about the role of M-CSF in the develop- 
ment of neointimal hyperplasia following mechanical vascular injury. We examined the 
expression of M-CSF and its receptor, c-fms, in rodent and rabbit models of arterial 
injury. Injured rat carotid arteries expressed 3- to lo-fold higher levels of M-CSF and c- 
fms mRNA within 24 hours following balloon injury as compared to uninjured arteries. 
The levels of mRNA paralleled the expression of immunoreactive M-CSF and ofms pro- 
tein. In the rabbit, M-CSF protein expression was greatest in neointimal smooth muscle 
cells (SMCs) post injury, with some expression also observed in medial SMCs. M-CSF- 
positive neointimal and medial SMCs exhibited markers of proliferation. At 30 days post 
injury, neointimal SMCs in the adjacent healed area near the border between injured and 
uninjured zone lost both proliferative activity and overexpression of M-CSF. The pres- 
ence of induced M-CSF and cfms expression correlated with the initiation of SMCs pro- 
liferation. We, therefore, investigated in vitro the effect of exogenous M-CSF on the 
proliferation of cultured human aortic SMCs (HASMCs). Recombinant human M-CSF 
stimulated an increase in the incorporation of PH] thymidine in HASMCs in a concentra- 
tion-dependent manner, and this effect was inhibited by a rat monoclonal antibody spe- 
cific to the cell surface epitope of human c-/rns. The presence of c-fms transcript and 
protein in HASMCs was demonstrated by Northern and Western blot analysis, respec- 
tiiely To test further the role of M-CSF in viva, we induced arterial injury by placing a 
periadventitial cuff around the carotid arteries in compound mutant mice lacking apolipo- 
protein (ape) E and M-CSF. Homozygous loss of M-CSF (the op mutation) abolished the 
neointimal hyperplastic response to arterial injury in apo E knockout mice. Local delivery 
of M-CSF to the injured artery restored neointimal proliferation. Taken together, our 
experimental studies suggest a critical role for M-CSF signaling through c-tmsfor neoint- 
imal thickening in response to arterial injury. 
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813-l Elevated Baseline C-Reactive Protein is Associated 
With Increased Risk of Death and Myocardial Infarction 
at One Year Following Percutaneous Coronary 
Intervention 
Joel P. Reginelfi, David S. Lee, Derek P. Chew, Ivan P. Casserly, Kent Dauterman, Kent 
W. Dauterman, Stephen G. Ellis, The Cleveland Clinic Foundation, Cleveland, OH 
Background: An elevated baseline C-reactive protein (CRP) prior to PCI has been asso- 
ciated with worse outcomes at 30 days; however, the longer term prognostic significance 
of an elevated value is not well established. We sought to determine if an elevated base- 
line CRP prior to PCI impacts long-term outcomes at l-year. Methods: Using a single- 
center intewentional registry database, we identified 1644 consecutive PCI patients in 
whom baseline pm-procedural CRP values were prospectively collected. Patients were 
divided into 4 quartiles (Q) based on CRP value (in mg/dl): 01<0.16, Q2=0.16-0.40, 
Q3=0.41-1.10, and Q471.10. One year outcome data, including death and Ml, were col- 
lected on all oatients. Results: For each increasino ouartile of CRP. there was a sionifi- 
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cantly increased risk of death (Figure) and death/Ml at one year (death-X2=66, p<O.OiOl; 
death/MI-&43. ocO.0001). Usina a Cox orooortional hazards model to adiust for con- 
I” 
founding by age, lesion score, LVEF. ACS, renal insufficiency, BMI, and statin therapy, 
baseline CRP remains a significant predictor of l-year death or Ml (HR=1.24 [CI=l.OB- 
